Latest Breaking News On - Negotiation program - Page 7 : comparemela.com

Major pharmaceutical firms are fighting a new federal program that empowers the government to negotiate lower prices for drugs that are widely prescribed in the Medicare system. The Washington Post’s Tony Romm reports Monday that the companies are engaged in a “vigorous legal battle” to undo the new program, which was authorized by the Inflation Reduction Act signed into law by President Joe Biden in 2022. Last week, lawyers for four of the companies affected by the new rule – Bristol Myers Squi

United statesWhite houseDistrict of columbiaJoe bidenTony rommNovo nordiskSupreme courtBristol myers squibbWashington postInflation reduction actPresident joe bidenInflation reductionPrice negotiationNegotiation programFederal programPower prices